Abstract

Sugammadex is a novel pharmacologic agent, which reverses neuromuscular blockade (NMB) via a mechanism that differs completely from acetylcholinesterase inhibitors. By encapsulating rocuronium, sugammadex can provide recovery of neuromuscular function even when there is a profound degree of NMB. We report anecdotal experience with the use of sugammadex to reverse NMB to facilitate intraoperative neurophysiological monitoring (motor evoked potentials) in an adolescent with scoliosis during posterior spinal fusion. Its potential application in this unique clinical scenario is discussed, and potential dosing schemes are reviewed.

Details

Title
Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
Author
Trifa, Mehdi 1 ; Krishna, Senthil 2 ; D'Mello, Ajay 2 ; Hakim, Mumin 3 ; Tobias, Joseph 2 

 Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA; Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia 
 Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital; Department of Anesthesiology and Pain Medicine, The Ohio State University College of Medicine, Columbus, Ohio 
 Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio 
Pages
219-221
Publication year
2017
Publication date
Apr/Jun 2017
Publisher
Medknow Publications & Media Pvt. Ltd.
ISSN
1658354X
e-ISSN
09753125
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2112126890
Copyright
© 2017. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.